New heart pill aims to keep patients out of hospital

NCT ID NCT07444398

Recruiting now Disease control Sponsor: Khawaja Danish Ali Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding a drug called Vericiguat to standard heart failure treatment helps people with suddenly worsening symptoms. Researchers will compare Vericiguat against a placebo in 130 patients to see if it reduces hospital stays and deaths from heart problems over three months. The main goal is to see if this additional medication provides better control of the disease.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPENSATED HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Armed Forces Institute of Cardiology. Pakistan
RECRUITING

Rawalpindi, Punjab Province, 46000, Pakistan

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DECOMPENSATED HEART FAILURE